Investigational Site Number 840011 — Tullahoma, Tennessee

Investigational Site Number 840011 is a clinical research site located in Tullahoma, Tennessee, United States 37388.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840011 has participated in 1 clinical trials.

Therapeutic areas: Arrhythmia Prophylaxis, Ventricular Arrhythmia.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tullahoma

Browse all research sites in Tennessee · View every site in Tullahoma

• Tennessee Center for Clinical Trials
• Research Site
• GSK Investigational Site
• Trinity Clinical Research
• Novo Nordisk Investigational Site
• Pediatric Clinical Trials of Tennessee, LLC
• Pediatric Clinical Trials Tullahoma-Site Number:8400062
• Pediatric Clinical Trials, LLC
• Pediatric Clinical Trials Tullahoma Site Number : 8400033
• Pearl Investigative Site
• Pearl Therapeutics Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840011?

Investigational Site Number 840011 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840011 conducted?

Investigational Site Number 840011 has 1 clinical trials on record. Their work covers Arrhythmia Prophylaxis, Ventricular Arrhythmia.

Is Investigational Site Number 840011 accredited by Crixeo Clinical Trials?

Investigational Site Number 840011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840011?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.